NEW YORK, April 29, 2025 /PRNewswire/ — Ro today announced an integration with NovoCare® Pharmacy to provide seamless access to all doses of Wegovy® at the best available cash price of $499 per month. By working directly with Novo Nordisk’s direct-to-patient option NovoCare® Pharmacy, Ro ensures patients have a reliable supply of FDA-approved GLP-1 medication directly from the manufacturer. With Ro’s streamlined experience, patients can consult with a provider and get access to effective GLP-1 medication at the lowest cash price, without ever having to leave the Ro app.

Read more here.